Skip to main content
. 2015 Jul 1;10(7):e0129898. doi: 10.1371/journal.pone.0129898

Fig 1. Consort 2010 Flow Diagram for the KTS-2-2010 study.

Fig 1

Consort Flow Diagram for the KTS-2-2010 study, with enrollment, allocation to induction and maintenance rituximab treatment, and follow-up showing number of patients who withdrew from study before 36 months.